Effects of adrenergics, adrenolytics, cholinergics and carbonic anhydrase inhibitors on ibopamine-induced ocular hypertension in POAG.
Virno
M
M
Eye Clinic, University La Sapienza of Rome.
De Gregorio
F
F
D'Ubaldo
E
E
Sallucci
S
S
De Stefano
C
C
Sedran
L
L
D000322:Adrenergic Agonists / Q000494:pharmacology*; D018674:Adrenergic Antagonists / Q000494:pharmacology*; D001082:Aqueous Humor / Q000378:metabolism; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology*; D018679:Cholinergic Agonists / Q000494:pharmacology*; D003846:Deoxyepinephrine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors; D018491:Dopamine Agonists / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005902:Glaucoma, Open-Angle / Q000150:complications*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D009798:Ocular Hypertension / Q000139:chemically induced* / Q000150:complications; D009883:Ophthalmic Solutions; D014065:Tonometry, Ocular
D000322:Adrenergic Agonists; D018674:Adrenergic Antagonists; D002257:Carbonic Anhydrase Inhibitors; D018679:Cholinergic Agonists; D018491:Dopamine Agonists; D009883:Ophthalmic Solutions; C023487:ibopamine; D003846:Deoxyepinephrine